By proceeding, you agree to our Terms of Use and Privacy Policy.
Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics.
04-05 May 2022
Arena International are delighted to announce Outsourcing in Clinical Trials Europe will be returning to Barcelona for our in-person event on the 4th & 5th May 2022! For the 12th Annual event, our flagship European clinical show will provide delegate
Event Ended
Spain
Paid
Barcelona
19-20 July 2022
Discover effective strategies for oncology trial operations to ensure trials run smoothly and within budget.
USA
Newton
19-22 September 2022
Across 3 main conference days and 8 tracks, 200+ CAR and TCR experts will lead you and your peers in discussions from novel allogeneic approaches with enhanced safety considerations, the latest in vivo gene engineering techniques, and advances in CMC
Boston
02-04 November 2022
Biologic drug discovery, development, manufacturing, pricing & market access, Clinical Trials. The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain.
Switzerland
Basel
14-17 November 2022
The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.
Sitges
06-08 March 2023
For almost 3 decades, the Molecular & Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community.
Hybrid
San Diego
16-20 May 2023
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting, which we've expanded to four full days in 2023, is the best place for people in the field to learn fr
Los Angeles
05-07 September 2023
Developing safe and effective gene therapies using AAV vectors is hindered by challenges related to the immune response. However, over the past two decades, drug developers have identified and are working on solutions to various immune responses to A